Diamonds and Dogs
8/28/17
Kite Pharma (KITE) is flying high. The drug company is jumping 28% after agreeing to be acquired by Gilead for $180 a share or $11.9 billion. Gilead wants Kite for their pipeline of blood cancer drugs with huge potential for their Axi-Cel drug in hematological malignancies. A good day for Kite shareholders. Their stock is up 400% for the year. Not bad.
Hurricane Harvey hitting the insurance stocks. Travelers (TRV) stock is down 3% not far from the spring lows as Hurricane Harvey quickly turning into the worst hurricane to hit the U.S. mainland in more than a decade. Harvey has lingered over Texas for days dropping over 30 inches of rain on Houston and expected to drop over 50 inches of rain in other places.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.
Find us on Facebook